Loading insider details...
Latest Form 4 (Feb 12, 2026): Disposition to Issuer of 219,905 AVDL shares, $4.62M.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Feb 12, 2026 | AVADEL PHARMACEUTICALS PLC (AVDL) | Disposition to Issuer | 219,905 | $4.62M |
| Jul 31, 2025 | AVADEL PHARMACEUTICALS PLC (AVDL) | Grant/Award | 11,000 | n/a |
| Jan 14, 2025 | AVADEL PHARMACEUTICALS PLC (AVDL) | Purchase | 30,000 | $235.2K |
| Aug 1, 2024 | AVADEL PHARMACEUTICALS PLC (AVDL) | Grant/Award | 11,000 | n/a |
| Nov 3, 2023 | Matinas BioPharma Holdings, Inc. (MTNB) | Grant/Award | 437,244 | n/a |
| Aug 3, 2023 | AVADEL PHARMACEUTICALS PLC (AVDL) | Grant/Award | 33,000 | n/a |
| May 19, 2023 | AVADEL PHARMACEUTICALS PLC (AVDL) | Purchase | 13,000 | $181.1K |
| Nov 23, 2022 | AVADEL PHARMACEUTICALS PLC (AVDL) | Purchase | 20,000 | $156.1K |
| Nov 16, 2022 | Matinas BioPharma Holdings, Inc. (MTNB) | Grant/Award | 142,657 | n/a |
| Aug 5, 2022 | AVADEL PHARMACEUTICALS PLC (AVDL) | Grant/Award | 42,000 | n/a |